Research and Clinical Trials

Title  
Deflazacort MP-104-CL-037
Brief Description  
The research program is an open label, expanded access program which intends to provide US children, adolescents, and/or adult patients with DMD access to treatment with deflazacort who are ineligible, unable, or otherwise unwilling to enroll in a clinical study examining the efficacy of deflazacort while a marketing application is under preparation and review. In addition, this research program will collect long-term safety and tolerability data from participants.
Who may be Eligible  
Patients with DMD who are = 5 years old and are unable or unwilling to participate in any other clinical studies examining how deflazacort works.
Start Date  
01/01/2016
IRB Number  
02-16-01A
Principal Investigator  
Bravver, Elena
Contact Name  
Allison

For More Information, Contact   Allison  Newell-Sturdivant , RN
Phone:  (704) 355-5285  Fax:  (704) 446-0840 
Email:  Allison.Newell-Sturdivant@carolinashealthcare.org
Address:  Neurosciences Institute, Neurology-Charlotte
1010 Edgehill Road North
Charlotte, NC 28207
Close